These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7911380)

  • 1. Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms.
    Dockhorn-Dworniczak B; Poremba C; Dantcheva R; Stücker A; Brömmelkamp E; Blasius S; Mellin W; Roessner A; Yandell DW; Böcker W
    Virchows Arch; 1994; 424(4):337-42. PubMed ID: 7911380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
    Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
    Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
    Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
    Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas.
    Park SY; Kang YS; Kim BG; Lee SH; Lee ED; Lee KH; Park KB; Lee JH
    Cancer Genet Cytogenet; 1995 Jan; 79(1):74-8. PubMed ID: 7850756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism.
    Jones MH; Nakamura Y
    Genes Chromosomes Cancer; 1992 Jul; 5(1):89-90. PubMed ID: 1384667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
    von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
    Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
    Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
    Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new polymorphic site in intron 2 of TP53 characterizes LOH in human tumors by PCR-SSCP.
    Oliva MR; Saez GT; Latres E; Cordon-Cardo C
    Diagn Mol Pathol; 1995 Mar; 4(1):54-8. PubMed ID: 7735557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and spectrum of p53 mutations in gastric cancer--a molecular genetic and immunohistochemical study.
    Poremba C; Yandell DW; Huang Q; Little JB; Mellin W; Schmid KW; Böcker W; Dockhorn-Dworniczak B
    Virchows Arch; 1995; 426(5):447-55. PubMed ID: 7633655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
    Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
    J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human breast cancer: frequent p53 allele loss and protein overexpression.
    Singh S; Simon M; Meybohm I; Jantke I; Jonat W; Maass H; Goedde HW
    Hum Genet; 1993 Feb; 90(6):635-40. PubMed ID: 8444469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid diagnosis of Miller-Dieker syndrome and isolated lissencephaly sequence by the polymerase chain reaction.
    Batanian JR; Ledbetter SA; Wolff RK; Nakamura Y; White R; Dobyns WB; Ledbetter DH
    Hum Genet; 1990 Oct; 85(5):555-9. PubMed ID: 2227942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of p53 gene mutations in human endometrial carcinomas.
    Honda T; Kato H; Imamura T; Gima T; Nishida J; Sasaki M; Hoshi K; Sato A; Wake N
    Int J Cancer; 1993 Apr; 53(6):963-7. PubMed ID: 8473053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of Southern blot and polymerase chain reaction as techniques to identify loss of DNA heterozygosity in colorectal cancer.
    Hewett PJ; Firgaira F; Morley A
    Aust N Z J Surg; 1994 Aug; 64(8):556-7. PubMed ID: 8048895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor.
    White GR; Stack M; Santibáñez-Koref M; Liscia DS; Venesio T; Wang JC; Helms C; Donis-Keller H; Betticher DC; Altermatt HJ; Hoban PR; Heighway J
    Br J Cancer; 1996 Sep; 74(6):863-70. PubMed ID: 8826850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumorigenesis.
    Gómez L; Rubio MP; Martin MT; Vázquez JJ; Idoate M; Pastorfide G; Pestaña A; Seizinger BR; Barnhill RL; Castresana JS
    J Invest Dermatol; 1996 Mar; 106(3):432-6. PubMed ID: 8648172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU
    Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.